Previous 10 | Next 10 |
2023-05-10 07:35:00 ET Summary Charlie Munger, vice chairman of Berkshire Hathaway Inc., brings a wealth of investment wisdom, priceless for those who seek to learn. Everyone has different requirements and priorities; we will mimic, but not mirror, his investing style. We disc...
2023-05-10 03:28:34 ET Summary You want exposure to the healthcare sector in your retirement portfolio. HQH fund has a 35-year track of outperforming and returning value to investors. It comes with an attractive discount not seen since March 2020. Tekla Healthcare In...
2023-04-16 14:00:00 ET Summary There are generally two separate issues with respect to leaving an estate – spouses and everyone else. Spouses should generally plan to generate enough income to sustain the longer-lived spouse – this means that the spouse who passes fi...
2023-04-12 02:26:28 ET Summary The White House's announcement on drug price caps caused a significant drop in biopharma stocks during Q1 2023. The impact of drug pricing-related caps and pressure will likely be limited, and the industry is expected to adapt and find new revenue st...
2023-04-10 08:00:00 ET Summary Legendary fund manager John Neff was a fan of big yields. Investment success does not require glamour stocks or bull markets. - John Neff. Mr. Neff saw healthy dividend income as a defense against market swings. We are buying 2 deeply discoun...
2023-03-09 05:23:39 ET Summary First Trust CEF Income Opportunity ETF is an actively managed fund of funds. It has outperformed its competitors YYY and PCEF since 2016. Distribution growth has outpaced inflation, but share price has lagged it. The main issues of this fund ...
2023-03-05 07:56:14 ET Summary The HQH fund aims to provide high total returns through investments in the healthcare industry. HQH has a high allocation to risky biotech stocks and private investments. The fund pays a 2% of NAV quarterly distribution. However, HQH has under-earned...
Summary CEFs trend towards a reversion to mean over time. We find two funds trading outside of their normal discount/premium. One of our picks gives high levels of tax-free income. Co-produced with Treading Softly. For years you have been surrounded by forces of na...
Tekla Healthcare Investors ( NYSE: HQH ) declares $0.42/share quarterly dividend , 7.7% increase from prior dividend of $0.39. Forward yield 8.97% Payable March 31; for shareholders of record Feb. 27; ex-div Feb. 24. See HQH Dividend Scorecard, Yield Chart, &...
Summary Ascendis is a mid-cap commercial biotech based in Denmark. Currently, it trades around $6.7B market cap, and the company holds $900M cash. Skytrofa (TransCon hGh) is Ascendis' lead approved agent for pediatric growth hormone deficiency (GHD), where the commercial update was luke...
News, Short Squeeze, Breakout and More Instantly...
Tekla Healthcare Investors Company Name:
HQH Stock Symbol:
NYSE Market:
2024-04-22 03:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-02 07:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-23 06:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...